BD solutions, including flow cytometers, software, conjugated antibodies, and services, are designed to support the rapid pace of discovery in T-cell research. Our solutions for T-cell identification, transcription factor expression, as well as cytokine secretion and measurement, reflect a commitment to high quality and consistency needed for advanced research.
To meet customer requirements, a range of choices is offered, from complete kits for phenotyping and sorting to fully customized formulas.
Charter Medical, Ltd. is a subsidiary of Fenner PLC. We have a 25 year history of developing and providing specialty single-use products to the blood transfusion, cell therapy, biotechnology and pharmaceutical markets. Charter Medical is committed to providing quality products and excellent service on-time every day. We will exceed customers’ expectations by integrating continuous improvements and ensuring compliance with regulatory requirements in everything we do.
Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine and advance cell therapy companies, organizations and institutions. Cognate provides specialized custom services to companies across all points of clinical and commercial development ranging from early preclinical studies, to mid phase trials and product scale-up though later stage clinical trials and commercial manufacturing.
As a not-for-profit research and development company, Draper focuses on the design, development and deployment of advanced technological solutions for the world’s most challenging and important problems. Draper’s Biomedical Solutions encompass organ-on-chip systems, cell therapy bioprocessing devices, rapid diagnostics, and neurotechnology.
Fresenius Kabi is a leading global health care company that focuses on pharmaceuticals and medical devices used to care for critically and chronically ill patients. Through our recent acquisition of Fenwal, we bring over 60 years experience advancing the fields of cell collection and separation with a deep expertise in closed-system processing. We recently launched Lovo, the only cell processing system that washes and concentrates white blood cells using filtration technology, specifically to serve the needs of the cellular therapies community.
IsoPlexis is dedicated to accelerating the fight against cancer and a range of our toughest diseases by producing the world’s most precise detection systems. We succeed by merging top engineering with top researchers and clinicians to generate clear solutions to complex patient response.
Irvine Scientific, a member of JXTG Group, is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivalled service and quality to scientists working in cell therapy and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. Read more here.
NanoCool uses innovative technology to create cost-effective, compact, uncomplicated packaging that meets your temperature controlled packaging needs. On-demand 2-8°C prequalified packaging systems, which use NanoCool’s unique evaporative cooling technology, are ideal for shipment of collected specimens over 2-4 days. No preparation of the packaging is required. NanoCool insulated shippers use less dry ice for extended duration shipments of frozen products, maintaining -65°C for 4-6 days.
Panasonic Healthcare Corporation of North America is a subsidiary of Panasonic Healthcare Holdings Co., Ltd. Tokyo, Japan, a global leader in development, design and manufacturing of laboratory equipment for biopharmaceutical, life sciences, academic, healthcare and government markets. Read more here.
PCT is the global cell therapy manufacturing and development service platform of the Hitachi Chemical Regenerative Medicine Business Sector, leveraging nearly two decades of PCT platform experience exclusively focused on the cell therapy industry. The PCT service platform includes contract development and manufacturing organization (CDMO) services, at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. Read more here.